Advanced search
Publication Cover
Clinical Ophthalmology Volume 16, 2022 - Issue
Submit an article Journal homepage
151
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema

Thi Ha Chau Tran1 Ophthalmology Department, Lille Catholic Hospitals, Lille Catholic University, INSERM, U1172, Lille, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9066-7092View further author information
ORCID Icon,
Stephane Verdun2 Biostatistics Department-Delegations for Clinical Research and Innovation, Lille Catholic Hospitals, Lille, FranceORCID Iconhttps://orcid.org/0000-0002-1381-3540View further author information
ORCID Icon,
Jean François Le Rouic3 Institut d’Ophtalmologie de l’Ouest, Nantes, FranceView further author information
,
Joel Uzzan4 Clinique Mathilde, Rouen, FranceORCID Iconhttps://orcid.org/0000-0001-6686-4854View further author information
ORCID Icon,
Solange Milazzo5 Ophthalmology Department, Picardie Jules Verne University, Amiens, FranceView further author information
,
Laurent Kodjikian6 Ophthalmology Department, Hospice Civils de Lyon, Lyon 1 University, UMR-CNRS 5510, Lyon, FranceORCID Iconhttps://orcid.org/0000-0002-3908-6716View further author information
ORCID Icon &
Ali Erginay7 Ophthalmology Department, Lariboisière Hospital, Paris University, Paris, FranceORCID Iconhttps://orcid.org/0000-0003-1960-3437View further author information
ORCID Icon show all
Pages 603-609 | Published online: 07 Mar 2022

References

  • Tranos PG, Wickremasinghe S, Stangos N, et al. Macular edema. Surv Ophthalmol. 2004;49:470–490. doi:10.1016/S0039-6257(04)00109-2
  • Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237:185–222. doi:10.1159/000458539
  • Do DV, Nguyen QD, Vitti R, et al. Intravitreal aflibercept injection in diabetic macular edema patients with and without prior anti-vascular endothelial growth factor treatment: outcomes from the Phase 3 program. Ophthalmology. 2016;123:850–857. doi:10.1016/j.ophtha.2015.11.008
  • Korobelnik JF, Do DV, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121:2247–2254. doi:10.1016/j.ophtha.2014.05.006
  • Heier JS, Bressler NM, Avery RL, et al. Comparison of aflibercept, bevacizumab, and ranibizumab for treatment of diabetic macular edema: extrapolation of data to clinical practice. JAMA Ophthalmol. 2016;134:95–99. doi:10.1001/jamaophthalmol.2015.4110
  • Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology. 2016;123:1351–1359. doi:10.1016/j.ophtha.2016.02.022
  • Bahrami B, Hong T, Schlub TE, Chang AA. Aflibercept for persistent diabetic macular edema: forty-eight-week outcomes. Retina. 2019;39:61–68. doi:10.1097/IAE.0000000000002253
  • Kulikov AN, Sosnovskii SV, Berezin RD, et al. Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study. Clin Ophthalmol. 2017;11:1995–2002. doi:10.2147/OPTH.S146019
  • Hagenau F, Vogt D, Ziada J, et al. Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface. Am J Ophthalmol. 2019;200:34–46. doi:10.1016/j.ajo.2018.12.004
  • Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M. Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and nonvitrectomized macaque eyes. Invest Ophthalmol Vis Sci. 2015;56:6501–6505. doi:10.1167/iovs.15-17279
  • Tran THC, Erginay A, Verdun S, et al. One-year outcome of aflibercept intravitreal injection in vitrectomized eyes with diabetic macular edema. Clin Ophthalmol. 2021;15:1971–1978. doi:10.2147/OPTH.S304030
  • Turkseven Kumral E, Ercalik NY. Intravitreal ranibizumab versus aflibercept for diabetic macular edema in vitrectomized eyes: 12 month results. Semin Ophthalmol. 2021;34:1–5.
  • Avitabile T, Azzolini C, Bandello F, et al. Aflibercept in the treatment of diabetic macular edema: a review and consensus paper. Eur J Ophthalmol. 2017;27:627–639. doi:10.5301/ejo.5001053
  • Michalewska Z, Stewart MW, Landers MB, et al. Vitrectomy in the management of diabetic macular edema in treatment-naive patients. Can J Ophthalmol. 2018;53:402–407. doi:10.1016/j.jcjo.2017.10.011
  • Bressler SB, Melia M, Glassman AR, et al. Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy before anti-vascular endothelial growth factor therapy. Retina. 2015;35:2516–2528. doi:10.1097/IAE.0000000000000617
  • Ciulla TA, Bracha P, Pollack J, Williams DF. Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States. Ophthalmology Retina. 2018;2:1179–1187. doi:10.1016/j.oret.2018.06.004
  • Chen YY, Chen PY, Chen FT, Chen YJ, Wang JK. Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema. Int Ophthalmol. 2018;38:293–299. doi:10.1007/s10792-017-0462-1
  • Wykoff CC, Shah C, Dhoot D, et al. Longitudinal retinal perfusion status in eyes with diabetic macular edema receiving intravitreal aflibercept or laser in vista study. Ophthalmology. 2019;126:1171–1180. doi:10.1016/j.ophtha.2019.03.040
  • Koyanagi Y, Yoshida S, Kobayashi Y, et al. Visual outcomes based on early response to anti-vascular endothelial growth factor treatment for diabetic macular edema. Ophthalmologica. 2018;239:94–102. doi:10.1159/000481711
  • Kakinoki M, Sawada O, Sawada T, et al. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Invest Ophthalmol Vis Sci. 2012;53:5877–5880. doi:10.1167/iovs.12-10164

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.